Company
Sermonix
Passion & Purpose in Women’s Oncology
Also known as Sermonix Pharmaceuticals
- Status
- Operatingas of 2026-09-20
- Business model
- B2B
- Headquarters
- Ohio, United States
- Founded
- 2014
- sermonixpharma.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Founded in late 2014 by David Portman, MD, a leading clinical researcher and expert in women’s health, Sermonix Pharmaceuticals is a privately held biotechnology company focused on the development and commercialization of female-specific oncology products.
Funding snapshot
- Total raised
- $42.8MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $40.2M2021-11-12
Funding rounds
- Round, 2021
- $40.2M2021-11-12, SEC form D sold, 9 investors
- Round, 2016
- $1.6M2016-07-05, SEC form D sold, 2 investors
- Round, 2015
- $1M2015-09-28, SEC form D sold, 17 investors
Products
- Other
- lasofoxifene
Loading relationship preview